Prediction of neurological outcome after cardiopulmonary resuscitation by serial determination of serum neuron-specific enolase

European Heart Journal

Volumn 28, Issue 1, 2007, Pages 52-58

  Reisinger, Johann ^a   Höllinger, Kurt ^a   Lang, Wolfgang ^a   Steiner, Christoph ^a   Winter, Thomas ^a   Zeindlhofer, Eduard ^a   Mori, Michael ^a   Schiller, Alexandra ^a   Lindorfer, Alexander ^a   Wiesinger, Kurt ^a   Siostrzonek, Peter ^a  

^a Krankenhaus der Barmherzigen Schwestern Wien Betriebsgesellschaft   (Austria)

Author keywords

Cardiopulmonary resuscitation; Neurological outcome; Neuron specific enolase

Indexed keywords

NEURON SPECIFIC ENOLASE;

ACCURACY; ADOLESCENT; ADULT; AGED; ANALGESIA; ARTICLE; CLINICAL OBSERVATION; COHORT ANALYSIS; COMA; CONTROLLED STUDY; DEATH; FEMALE; FOLLOW UP; GLASGOW COMA SCALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROLOGICAL COMPLICATION; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; RESUSCITATION; SEDATION; SENSITIVITY AND SPECIFICITY; UNCONSCIOUSNESS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARDIOPULMONARY RESUSCITATION; COHORT STUDIES; FEMALE; HEART ARREST; HUMANS; HYPOXIA, BRAIN; MALE; MIDDLE AGED; PHOSPHOPYRUVATE HYDRATASE; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 33846336512     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehl316     Document Type: Article

References (25)

1. Young GB. Ethics in the intensive care unit with emphasis on medical futility in comatose survivors of cardiac arrest. J Clin Neurophysiol 2000;17:453-456.
2. Schmechel D, Marangos PJ, Zis AP, Brightman M, Goodwin FK. Brain enolases as specific markers of neuronal and glial cells. Science 1978;199:313-315.
3. Marangos PJ, Schmechel DE. Neuron specific enolase, a clinically useful marker for neurons and neuroendocrine cells. Annu Rev Neurosci 1987;10:269-295.
4. Roine RO, Somer H, Kaste M, Viinikka L, Karonen SL. Neurological outcome after out-of-hospital cardiac arrest. Prediction by cerebrospinal fluid enzyme analysis. Arch Neurol 1989;46:753-756.
5. Schaarschmidt H, Prange HW, Reiber H. Neuron-specific enolase concentrations in blood as a prognostic parameter in cerebrovascular diseases. Stroke 1994;25:558-565.
6. Fogel W, Krieger D, Veith M, Adams HP, Hund E, Storch-Hagenlocher B, Buggle F, Mathias D, Hacke W. Serum neuron-specific enolase as early predictor of outcome after cardiac arrest. Crit Care Med 1997;25:1133-1138.
7. Martens P, Raabe A, Johnsson P. Serum S-100 and neuron-specific enolase for prediction of regaining consciousness after global cerebral ischemia. Stroke 1998;29:2363-2366.
8. Schoerkhuber W, Kittler H, Sterz F, Behringer W, Holzer M, Frossard M, Spitzauer S, Laggner AN. Time course of serum neuron-specific enolase. A predictor of neurological outcome in patients resuscitated from cardiac arrest. Stroke 1999;30:1598-1603.
9. Rosen H, Stibrant Sunnerhagen K, Herlitz J, Blomstrand C, Rosengren L. Serum levels of the brain-derived proteins S-100 and NSE predict long-term outcome after cardiac arrest. Resuscitation 2001;49:183-191.
10. Zingler VC, Krumm B, Bertsch T, Fassbender K, Pohlmann-Eden B. Early prediction of neurological outcome after cardiopulmonary resuscitation: a multimodal approach combining neurobiochemical and electrophysiological investigations may provide high prognostic certainty in patients after cardiac arrest. Eur Neurol 2003;49:79-84.
11. Meynaar IA, Oudemans-van Straaten HM, Wetering J, Verlooy P, Slaats EH, Bosman RJ, Spoel JI, Zandstra DF. Serum neuron-specific enolase predicts outcome in post-anoxic coma: a prospective cohort study. Intensive Care Med 2003;29:189-195.
12. Tiainen M, Roine RO, Pettilä V, Takkunen O. Serum neuron-specific enolase and S-100B Protein in cardiac arrest patients treated with hypothermia. Stroke 2003;34:2881-2886.
13. Pfeifer R, Börner A, Krack A, Sigusch HH, Surber R, Figulla HR. Outcome after cardiac arrest: predictive values and limitations of the neuroproteins neuron-specific enolase and protein S-100 and the Glasgow coma scale. Resuscitation 2005;65:49-55.
14. Zandbergen EG, Hijdra A, Koelman JH, Hart AA, Vos PE, Verbeek MM, de Haan RJ, PROPAC Study Group. Prediction of poor outcome within the first 3 days of postanoxic coma. Neurology 2006;66:62-68.
15. Zandbergen EGJ, de Haan RJ, Hijdra A. Systematic review of prediction of poor outcome in anoxic-ischaemic coma with biochemical markers of brain damage. Intensive Care Med 2001;27:1661-1667.
16. Wijdicks EFM, Hijdra A, Young GB, Bassetti CL,Wiebe S. Practice parameter: prediction of outcome in comatose survivors after cardiopulmonary resuscitation (an evidence-based review). Neurology 2006;67:203- 210.
17. Cummins RO, Chamberlain DA, Abramson NS, Allen M, Baskett PJ, Becker L, Bossaert L, Delooz HH, Dick WF, Eisenberg MS, Evans TR, Holmberg S, Kerber R, Mullie A, Ornato JP, Sandoe E, Skulberg A, Tunstall-Pedoe H, Swanson R, Thies WH. Recommended guidelines for uniform reporting of data from out-of-hospital cardiac arrest: the Utstein style. Circulation 1991;84:960-975.
18. Hypothermia After Cardiac Arrest Study Group. Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest. N Engl J Med 2002;346:549-556.
19. Beaudeux JL, Leger P, Dequen L, Gandjbakhch I, Coriat P, Foglietti MJ. Influence of hemolysis on the measurement of S-100β protein and neuron-specific enolase plasma concentrations during coronary artery bypass grafting. Clin Chem 2000;46:989-990.
20. Booth CM, Boone RH, Tomlinson G, Detsky AS. Is this patient dead, vegetative, or severely neurologically impaired? Assessing outcome for comatose survivors of cardiac arrest. JAMA 2004;291:870-879.
21. Zandbergen EGJ, de Haan RJ, Stoutenbeek CP, Koelman JHTM, Hijdra A. Systematic review of early prediction of poor outcome in anoxic-ischaemic coma. Lancet 1998;352:1808-1812.
22. Madl C, Kramer L, Domanovits H, Woolard RH, Gervais H, Gendo A, Eisenhuber E, Grimm G, Sterz F. Improved outcome prediction in unconscious cardiac arrest survivors with sensory evoked potentials compared with clinical assessment. Crit Care Med 2000;28:721-726.
23. Body JJ, Paesmans M, Sculier JP, Dabouis G, Bureau G, Libert P, Berchier MC, Raymakers N, Klastersky J. Monoclonal immunoradiometric assay and polyclonal radioimmunoassay compared for measuring neuron-specific enolase in patients with lung cancer. Clin Chem 1992;38:748-751.
24. Schmitt UM, Stieber P, Hasholzner U, Pahl H, Hofmann K, Fateh-Moghadam A. Methodological and clinical evaluation of two automated enzymatic immunoassays as compared with a radioimmunoassay for neuron-specific enolase. Eur J Clin Chem Clin Biochem 1996;34:679-682.
25. Ransohoff DF, Feinstein AR. Problems of spectrum and bias in evaluating the efficacy of diagnostic tests. N Engl J Med 1978;299:926-930.